0.3660
-0.0100
(-2.66%)
At close: 5:35 PM GMT+1
Loading Chart for Y7Q.SG
DELL
- Previous Close
0.3760 - Open
0.3840 - Bid 0.3660 x --
- Ask 0.4220 x --
- Day's Range
0.3660 - 0.3840 - 52 Week Range
0.2900 - 0.8080 - Volume
0 - Avg. Volume
123 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Nov 8, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: Y7Q.SG
View MorePerformance Overview: Y7Q.SG
Trailing total returns as of 11/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
Y7Q.SG
46.18%
S&P/TSX Composite index
21.61%
1-Year Return
Y7Q.SG
46.18%
S&P/TSX Composite index
26.79%
3-Year Return
Y7Q.SG
46.18%
S&P/TSX Composite index
20.65%
5-Year Return
Y7Q.SG
46.18%
S&P/TSX Composite index
49.62%
Compare To: Y7Q.SG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
0.3660
-2.66%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
8.72
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.1540
-3.17%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.1120
+8.53%
Mkt Cap EUR 56.21M
Industry Drug Manufacturers—Specialty & Generic
1.4280
-2.99%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
1.3780
-6.51%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0206
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0740
0.00%
Mkt Cap EUR 24.6M
Industry Drug Manufacturers—Specialty & Generic
4.2860
+2.54%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.79
+2.30%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
8.86
+3.57%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Statistics: Y7Q.SG
View MoreValuation Measures
As of 11/26/2024
Market Cap
132.49M
Enterprise Value
161.55M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.96
Price/Book (mrq)
0.85
Enterprise Value/Revenue
1.55
Enterprise Value/EBITDA
62.95
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--